CLINICAL STUDY EVALUATING TREATMENT OF DIABETIC FOOT ULCERS USING MICROCYN TECHNOLOGY PRESENTED AT STUTTGART2005

Oculus Innovative Sciences announced that Luca Dalla Paola, a surgeon with the diabetic foot unit of the Abano Terme Hospital in Italy, recently presented the results of a 218-patient controlled clinical study that assessed the safety and efficacy of Microcyn Technology in treating diabetic foot ulcers as compared to povidone iodine (10%) antiseptic, which is often used as the "standard care" in treatment of open wounds.
Yahoo News